Weekly 1-hour infusion of paclitaxel: Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma

Charu Trivedi, Bruce Redman, Lawrence E. Flaherty, Omer Kucuk, Wei Du, Lance K. Heilbrun, Maha Hussain*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Weekly 1-hour infusion of paclitaxel: Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry